4/25/24 - vrockstar - first time i come across this ticker (i look at a lot), wow. great opex flex. software-ish margins, not expensive on various multiples i look at vs. growth looks awesome. chart yes. am i missing anything frens, i think i'm just buying this print b/c i like everything i see including cash gen, captive industry that's bit less discretionary....
The white dotted line represents the Stocks average up trend, you can see the stock has squeezed down into an equal triangle (nor bullish or bearish) and looks bullish with that cup and handle right into the bottom. Looking for a safe gain to major resistance at $34.18 Daily RSI shows above 50 after a reset.
ResMed Inc. is a leader in digital health and cloud-connected medical devices. ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity...
ResMed Inc. (RMD) - Bullish Price Action Analysis Date: 28 Dec 2023 Overview: ResMed Inc. (RMD) is currently exhibiting signs of bullish price action. This analysis provides a potential trading outlook based on the stock's recent market behavior and technical analysis. Current Market Observations: Price Trend: RMD has shown a consistent upward trend in recent...
Base on trendline, this counter still in bullish condition. It just rebound at MA200 line. Target TP1 at price USD224
The PEAD projected a Bullish outlook for $RMD after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 50%.
RMD Buying ANalysis risky analysis for short-term long trade.
We like low beta stocks, and ResMed is one of them. Solid balance sheet and high profit margin. Not cheap based on P/E, but justified by high RoE and high margins.
SSI Live Trading Series Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK |...
The PEAD projected a Neutral outlook for $RMD after a Negative over reaction following its earnings release placing the stock in drift C.
Resmed has been on the nose of late and is very choppy in price action making it hard to navigate some analysis to buy. However, the conditions have now been met. Do you buy such a choppy price action?
📌ResMed sideway matket in last periods, price currently in CHANNEL pattern, fundamentally side ResMed is have today presentation at the Oppenheimer 32nd Annual Healthcare Conference, today we are can see bullish move, expecting now to see continuation. 💡 RMD technically based idea, we can see price is on SUPP zone, CHANNEL pattern visible, technically...
ENTRY: 261.39 SL: 232.75 TP1: 307.39 TP2: 316.43 - Weekly chart - Long term trading - ADX>20 - Maintaining at pivot point "P" and 38% fib. - Strength meter is red hence some weakness. - Entry based on breakout from VZ this week.
Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA |...
Resmed has been a very steady gainer over the last 12 months. Could be worth a look.
Consolidation could be broken upwards with a minimum target in the region of 280.